Bristol Myers Squibb to Report Results for First Quarter 2021 on April 29, 2021Business Wire • 03/11/21
Bristol-Myers Squibb Company (BMY) Presents at Barclays Global Healthcare Conference (Transcript)Seeking Alpha • 03/09/21
5 Stocks to Watch Amid Continued Expansion in the Biotech IndustryZacks Investment Research • 03/09/21
Is Bristol Myers Stock A Buy As Shares Flounder After Fourth-Quarter Beat?Investors Business Daily • 03/05/21
Bristol-Myers Squibb Co. (BMY) Management Presents at Cowen Virtual 41st Annual Health Care Conference Call TranscriptSeeking Alpha • 03/03/21
Bristol-Myers Squibb Co (BMY) Presents at 42nd Annual Raymond James Institutional Investor Conference (Transcript)Seeking Alpha • 03/02/21
Bristol Myers Squibb to Participate in Barclays Virtual Global Healthcare ConferenceBusiness Wire • 03/02/21
Bristol-Myers Squibb: Undervalued Dividend Contender, Offering Income, Dividend Growth, And Capital AppreciationSeeking Alpha • 02/28/21
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) in Combination with Cabometyx® (cabozantinib) as First-Line Treatment for Patients with Advanced Renal Cell CarcinomaBusiness Wire • 02/26/21
Press release Biocartis Group NV: BIOCARTIS ANNOUNCES 2020 RESULTS AND 2021 OUTLOOKGlobeNewsWire • 02/25/21
The New England Journal of Medicine Publishes Results from Pivotal Phase 2 KarMMa Study of Idecabtagene Vicleucel (Ide-cel, bb2121), an Investigational BCMA-Directed CAR T Cell TherapyBusiness Wire • 02/24/21
Bristol Myers Squibb to Take Part in the Cowen Virtual 41st Annual Health Care ConferenceBusiness Wire • 02/24/21